MARKET INTRODUCTION

Gastroparesis is a condition that affects the normal spontaneous movement of the muscles (motility) in your stomach. Gastroparesis can interfere with normal digestion, cause nausea and vomiting, and cause problems with blood sugar levels and nutrition.

MARKET DYNAMICS

Increase in prevalence of diabetes mellitus among people, as approximately 5 to 10% of insulin-dependent diabetics may progress to severe symptomatic gastroparesis. Moreover, rising incidences of gastroparesis, for instance, as per Swinburne University of Technology, more than 1.5 million Americans suffer from severe gastroparesis, and approximately 120,000 Australians are affected by the disorder. However, usage of OTC drugs, side effects of available gastroparesis drugs in future will impede the market growth.

MARKET SCOPE
`
The "Global Gastroparesis Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gastroparesis Market with detailed market segmentation by gastroparesis type, drug class type, distribution channel, end-use and geography. The Global Gastroparesis Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Gastroparesis Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Gastroparesis Market is segmented on the basis of gastroparesis type, drug class type, and distribution channel. Based on drug class type, the market has been categorized as prokinetic agents, botulinum toxin injection, and antiemetic agents. Based on gastroparesis type, the market has been categorized as idiopathic, diabetic, post-surgical, others. Based on distribution channel, the Gastroparesis market has been classified into retail pharmacies, hospital pharmacies, and others.?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Gastroparesis Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gastroparesis Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Gastroparesis Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gastroparesis Market in these regions.

MARKET PLAYERS

The report covers key developments in the Gastroparesis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Gastroparesis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Gastroparesis Market in the global market. Below mentioned is the list of few companies engaged in the Gastroparesis Market.

The report also includes the profiles of key Gastroparesis Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boston Scientific Corporation
- Cardinal Health, Inc.
- C. R. Bard, Inc.
- Abbott Laboratories
- Medtronic
- Salix Pharmaceuticals, Inc.
- Janssen Global Services, LLC
- Teva Pharmaceuticals
- Kimberly-Clark Corporation
- Rhythm Pharmaceuticals, Inc.
- Alfa Wassermann SPA
- Evoke Pharma